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Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxyben-
zo(g)-1,3-benzodioxolo (5,6-a) quinolizinium] is an alkaloid
present in plants of the Berberidaceae family and used in
traditional Chinese and North American medicine. We have
previously demonstrated that berberine causes mitochondrial
depolarization and fragmentation, with simultaneous increase in
oxidative stress. We also demonstrated that berberine causes an
inhibition of mitochondrial respiration and a decrease on calcium
loading capacity through induction of the mitochondrial perme-
ability transition (MPT). The objective of the present work is to
investigate a common target for both induction of the MPT and
inhibition of respiration. The hypothesis is that berberine induces
the MPT through interacting with the adenine nucleotide trans-
locator (ANT). By measuring induction of the MPT through
increased mitochondrial swelling, membrane depolarization and
loss of calcium retention, we observed that the effects of berberine
were not inhibited by bongkrekic acid although adenosine
diphosphate (ADP)/oligomycin completely prevented the MPT.
Also, we observed that berberine increased the depolarization
effect of oleic acid on liver mitochondria. The initial depolariza-
tion observed when berberine is added to mitochondria was not
affected by ANT inhibitors. Taken together, we propose that
berberine acts on the ANT, altering the binding of the protein to
bongkrekic acid but not to cyclosporin A or ADP. It is also clear
that the membrane potential is required for berberine effects, most
likely for allowing for its mitochondrial accumulation. Mitochon-
drial effects of berberine can be relevant not only for its proposed
antitumor activity but also for the assessment of its organ toxicity,
depending on factors such as tissue accumulation or delivery.
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Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethox-
ybenzo(g)-1,3-benzodioxolo (5,6-a) quinolizinium], a benzyl
tetra isoquinoline plant alkaloid derived from the Berber-
idaceae family, has been extensively used for many centuries.
In fact, extracts containing berberine have been used in the
traditional Chinese and Native American medicine. Berberine
chemical structure (Fig. 1) contains a quaternary base and it is
commercially available as various salts such as berberine
chloride and hemisulfate. Many pharmacological applications
have been attributed to berberine, such as antidiarrheic (Taylor
and Baird, 1995), antimicrobial (Kaneda et al., 1991), anti-
inflammatory (Ckless et al., 1995), antiarrhythmic (Hong et al.,
2002), antihypertensive (Hong et al., 2002), antiproliferative/
antitumoral (Letasiova et al., 2005; Serafim et al., 2008), and
as an antioxidant (Shirwaikar et al., 2006). It has also been
reported that berberine reduces glucose blood levels in diabetes
(Zhou et al., 2007), alters the processing of Alzheimer’s
amyloid precursor protein decreasing Ab secretion (Asai et al.,
2007), and shows antiangiogenic properties (Lin et al., 2004),
inhibiting HIF-a expression via enhanced proteolysis. Berber-
ine is metabolized in the liver by cytochrome P450, suffering
phase I metabolism (Pereira et al., 2007)
Previously, we demonstrated that berberine is selectively
accumulated by mitochondria on K1735-M2 melanoma cells,
arresting cell proliferation, causing mitochondrial fragmenta-
tion and depolarization, oxidative stress and a decrease in ATP
levels (Pereira et al., 2007). A decrease in the number of
mitochondria-like structures and in mitochondrial DNA copy
number was also found (Pereira et al., 2007). The work by
Barreto et al. (2003) also confirmed the relevance of positively
charges on the selective accumulation of alkaloids in
mitochondria. We have identified two distinct types of effects
of berberine on isolated mitochondrial fractions. Berberine
inhibits state 3 and uncoupled respiration, which is more
visible when complex I substrates are used (Pereira et al.,
2007). On the other hand, berberine also decreases mitochon-
drial calcium loading capacity through enhanced induction of
the mitochondrial permeability transition (MPT) (Pereira et al.,
2007). Through the analyses of several parameters, it is
proposed that berberine inhibits the phosphorylative system,
although no effects on the ATPase activity were observed
(Pereira et al., 2007). The interaction of berberine on both the
phosphorylative system and on the MPT suggests that
a common target may be involved. One interesting candidate
is the adenine nucleotide translocator (ANT).
The ANT is a mitochondrial inner membrane adenosine
diphosphate (ADP)-ATP antiporter that imports ADP to the
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matrix and exports ATP to the cytosol, being suggested to be
a structural component of the MPT pore (Armstrong, 2006),
although recent data cast doubts regarding this issue (Juhaszova
et al., 2008). The ANT alternates between two distinct
conformations in which adenine nucleotides are either bound
to the cytosolic side (c-state) or to the matrix side (m-state) of
the inner mitochondrial membrane. It has also been described
that the c-conformation is favorable to the MPT (Armstrong,
2006). Carboxyatractyloside which binds to ANT in the
c-state activates the MPT pore, whereas bongkrekic acid
which binds to ANT in the m-state inhibits the MPT pore.
The two ligands are known to be ANT specific inhibitors
(Armstrong, 2006).
The role of the ANT in the MPT has not been fully resolved.
Although the MPT is an inner membrane phenomenon, there is
substantial evidence of the involvement of the VDAC (voltage-
dependent anion channel) in the MPT. Crompton et al. (1998)
showed that matrix cyclophilin D (CycP-D), the third putative
component of the MPT, binds to complexes of VDAC and
ANT in order to form the MPT complex. It has also been
reported that CycP-D is more of a regulatory component of the
MPT pore than a structural one. Cyclosporin A (Cyc A) was
show to block the MPT by inhibiting the binding of CycP-D to
the ANT (Szabo and Zoratti, 1991).
MPT activation compromises the normal integrity of the
mitochondrial inner membrane resulting into uncoupled
oxidative phosphorylation, ATP decay, mitochondrial swelling
and release of apoptogenic factors, indicating a key role for the
MPT in apoptosis, although this subject is still controversial
(Armstrong, 2006).
In the present work, we proposed to investigate the
mechanism by which berberine induced the MPT pore in
isolated rat liver mitochondria; we hypothesize that berberine
induces that phenomenon by interacting with the ANT.
Experiments with specific ANT ligands (bongkrekic acid,
carboxyatractyloside) were performed in order to identify the
ANT as the site for berberine action on isolated liver
mitochondria.
MATERIALS AND METHODS
Materials. Berberine hemisulfate was obtained from Sigma-Aldrich
(St Louis, MO) and prepared in dimethyl sulfoxide (DMSO), which is routinely
used as a solvent for isolated mitochondrial studies. The total volume of DMSO
was always smaller than 0.1%, which had negligible effects in all experiments.
Concentrations used in this study were based in previous literature that showed
effects in both intact melanoma cells and isolated hepatic mitochondria (Pereira
et al., 2007).
Calcium Green-5N, hexapotassium salt, was obtained from Invitrogen
(Carlsbad, CA) and Bongkrekic acid was obtained from Calbiochem (San
Diego, CA, purity:  92% by high-performance liquid chromatography).
Carboxyatractyloside was obtained from Sigma-Aldrich.
All other compounds were of the highest grade of purity commercially
available.
Animals. Male Wistar rats (6–10 weeks old), housed at 22 ± 2C under
artificial light for a 12-h light/day cycle and with free access to water and food,
were used throughout the experiments. The research procedure was carried out
in accordance with the European Requirement for Vertebrate Animal Research
and within the internal Standards for Animal Research at the CNC.
Isolation of rat liver mitochondria. Mitochondria were isolated from livers
of male Wistar rats by conventional methods with slight modifications (Pereira et
al., 2007). Homogenization medium contained 250mM sucrose, 10mM 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), pH 7.4, 1mM EGTA,
and 0.1% fat-free bovine serum albumin (BSA). Ethylene-bis(oxyethylene-
nitrilo)tetraacetic acid (EGTA) and BSA were not present at the final washing
medium, adjusted at pH 7.4. The mitochondrial pellet was washed twice,
suspended in the washing medium, and immediately used. Protein content was
determined by the biuret method (Gornall et al., 1949) calibrated with BSA.
Mitochondrial swelling. Mitochondrial volume changes were followed by
the decrease of absorbance at 540 nm with a Jasco V-560 spectrophotometer
(Jasco, Tokyo, Japan). The assays were performed in 2 ml of the reaction
medium (200mM sucrose, 10mM Tris-HCl, pH 7.4, 10lM EGTA, 1mM
KH2PO4), 0.6lM rotenone plus 5mM succinate for complex II–related assays
or 5mM glutamate/malate for complex I assays to which 1.5 mg of
mitochondrial protein was added under constant stirring at 30C.
Calcium (26.7–53.3 nmol/mg protein) was added to the preparation
approximately 1 min after the start of the experiment. Cyc A (1lM) was
added to the mitochondrial preparation before the addition of calcium to inhibit
the MPT. Berberine was preincubated with the mitochondrial preparation for
approximately 1–2 min.
The ANT inhibitors carboxyatractyloside (2.5lM) and bongkrekic acid
(12.5lM) were also used in some experiments in order to modulate the effect of
berberine on the MPT. The concentrations of the two ANT inhibitors were
chosen with basis in preliminary experiments, regarding inhibition of ADP
phosphorylation and MPT modulation (data not shown). Both carboxyatracty-
loside and bongkrekic acid were added to the mitochondrial preparation before
calcium addition. Different concentrations of berberine were preincubated for
1 min with the mitochondrial preparation.
Mitochondrial calcium loading. Extramitochondrial free Ca2þ was
assayed by using the hexapotassium salt of the fluorescent probe Calcium
Green 5-N (1lM).
Liver mitochondria (0.75 mg) were suspended in 2 ml of buffer containing
200mM sucrose, 10mM Tris, 10lM EGTA, and 1mM KH2PO4. Rotenone
(0.6lM) and succinate (5mM) were also added to the media.
Fluorescence was continuously recorded in a water-jacketed cuvette holder
at 30C using a PerkinElmer LS-55 fluorescence spectrometer (PerkinElmer
Life and Analytical Sciences, Boston, MA) with excitation and emission
wavelengths of 506 and 531, respectively. Slits used were 5 nm for both
excitation and emission.
Different concentrations of berberine were added to the mitochondrial
preparation (0.75 mg), before the addition of calcium (10–13.3 nmol/mg
protein) which was made 1 min after the start of the experiment.
Cyc A (1 lM) was added to the mitochondrial preparation before the
addition of calcium to inhibit the MPT. In some assays, carboxyatractyloside
(2.5lM) and bongkrekic acid (12.5lM) were added before calcium addition.
Measurement of the mitochondrial transmembrane potential. The
mitochondrial transmembrane potential (Dw) was indirectly estimated by the
FIG. 1. Chemical structure of berberine.
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mitochondrial accumulation of the lipophilic cation—tetraphenylphosphonium
cation (TPPþ) as detected by using a TPPþ selective electrode in combination with
an Ag/AgCl saturated reference electrode. Both the TPPþ electrode and the
reference electrode were inserted into an open vessel with magnetic stirring and
were connected to a pH meter (model 3305, Jenway, Essex, UK). The signals were
fed into a potentiometric recorder (model BD 121,Kipp & Zonen B.V., Delft, The
Netherlands). No correction was made for ‘‘passive’’ binding of TPPþ to the
mitochondrial membranes because the purpose of the experiments was to show
relative changes in potentials rather than absolute values.
Mitochondrial protein (1.5 mg) was suspended under constant stirring in
1 ml of reaction medium composed 125mM sucrose, 65mM KCl, 5mM
KH2PO4, 2.5mM MgCl2, and 5mM HEPES, pH 7.4 (30C), supplemented with
3lM TPPþ. Mitochondria were energized with 5mM of succinate plus 3lM
rotenone.
Different concentrations of berberine were added before mitochondrial
protein. Forty to 53.3 nmol of calcium/mg protein was added to initiate the
MPT.
Absolute values for membrane potential (in mV) were determined from the
equation originally proposed by (Kamo et al., 1979), assuming Nernst
distribution of the ion across the membrane electrode.
Cyc A (1lM) was added to the mitochondrial preparation before the
addition of calcium to inhibit the MPT. As described before, carboxyatractylo-
side (2.5lM), bongkrekic acid (12.5lM), or ADP (500lM) plus oligomycin
(20 lg) were also preincubated with mitochondria.
In order to investigate the effects of berberine on oleic acid–induced
depolarization, freshly isolated mitochondria (1.5 mg) were energized using
5mM succinate plus 3lM rotenone and were allowed to stabilize at the
maximum membrane potential for 60 s.
After DW stabilization, 0.84 nmol/mg (four additions total ¼ 6.88 nmol/mg
protein) of oleic acid was added to induce membrane depolarization. Different
concentrations of berberine were also added before initiating the assay.
In selected experiments, carboxyatractyloside (2.5lM) or carbonyl cyanide
4-(trifluoromethoxy)phenylhydrazone (FCCP) (0.1lM) was added to the
mitochondrial fractions.
Statistical analysis. Data are expressed as means ± SEM and evaluated by
one-away ANOVA followed by Bonferroni multiple comparison tests.
Differences were considered significant if the p < 0.05.
RESULTS
Berberine Induces the MPT in Isolated Hepatic
Mitochondrial Fractions
Calcium-dependent mitochondrial swelling measured by
light scattering at 540 nm is a characteristic measure of MPT
induction (Hunter and Haworth, 1979). In a first approach we
investigated whether berberine was able to induce the MPT
with complex I substrates, in a similar fashion to what was
previously observed for complex II substrates (Pereira et al.,
2007). Figures 2A–D demonstrate that berberine in a dose-
dependent fashion was able to induce mitochondrial swelling
upon calcium addition, irrespective of the substrate used.
FIG. 2. Mitochondria were incubated with different concentrations of 13.3, 33.3 and 66.7 nmol berberine/mg protein and with succinate plus rotenone or
glutamate/malate as substrates. Calcium (26.7–53.3 nmol/mg protein) was added to the preparation in order to induce the MPT pore. (A and C) Typical recording
and amplitude of swelling recorded 400 s after calcium addition, when glutamate-malate was used as substrate. (B and D) Typical recording and amplitude of
swelling recorded 400 s after calcium addition, when succinate was used as substrate. (C and D) Bars represent the mean ± SEM of 6/7 different preparations. (*)
Statistically different compared with the control (p < 0.05). (A and B) 0, reference line; 1, control; 2, 13.3 nmol berberine/mg protein; 3, 33.3 nmol berberine/mg
protein; 4, 66.7 nmol berberine/mg protein.
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Succinate was then used as the substrate for the following
experiments regarding MPT induction.
We followed up the selecting one berberine concentration
(133.3 nmol/mg protein) and investigating whether classic
ANT inhibitors such as carboxyatractyloside and bongkrekic
acid could interfere with the action of berberine on the MPT
(Fig. 3). Bongkrekic acid was previously shown to inhibit MPT
induction in isolated hepatic (Vergun and Reynolds, 2005) and
cardiac mitochondria (Haworth and Hunter, 2000).
As expected, in the absence of berberine, bongkrekic acid
was able to inhibit the MPT, as opposed to carboxyatractylo-
side which increased calcium-induced mitochondrial swelling.
The most relevant result was that bongkrekic acid was not able
to inhibit berberine-induced mitochondrial swelling (Fig. 3B).
The addition of Cyc A, the classic MPT pore inhibitor
(Broekemeier et al., 1989), to mitochondria incubated with
bongkrekic acid plus berberine was able to decrease mito-
chondrial swelling.
In order to verify if berberine effects on MPT were
dependent on the mitochondrial transmembrane potential, we
performed swelling assays with nonenergized mitochondria,
where mitochondrial calcium loading was obtained through
a calcium ionophore.
The results described in Figure 4 demonstrate that in the
absence of a transmembrane electric potential, berberine does
not cause mitochondrial swelling in the presence of calcium.
Berberine Induces Mitochondrial Depolarization Dependent
on Calcium
Calcium-induced MPT opening leads to the loss of DW in
a Cyc A–sensitive fashion (Pereira et al., 2007). Figure 5
illustrates a typical experimental of measuring the effect
of different concentrations of berberine (6.7, 13.3, 33.3, and
66.7 nmol/mg protein) on calcium-induced mitochondrial
depolarization.
Mitochondria were preincubated with different concentra-
tions of berberine for 60 s after being energized with succinate.
Figure 5 shows typical recordings on the effect of berberine on
calcium-induced depolarization. A graphic pictured in Figure
5B describes the values of DW before, 5 and 10 min after
calcium addition.
The results show that 13.3, 33.3, and 66.7 nmol berberine/
mg protein significantly cause mitochondrial depolarization
upon calcium addition. Cyc A was able to prevent the loss of
DW in the presence of calcium. Confirming results obtained
with mitochondrial swelling, it was observed that the effect of
carboxyatractyloside is increased by the presence of berberine
(i.e., increasing calcium-induced depolarization) and that the
inhibitory effect of bongkrekic acid on the loss of DW is not
FIG. 3. Effects of ANT inhibitors on berberine-induced swelling. (A)
Typical recording. Mitochondria were preincubated with the presence and
absence of 133.3 nmol berberine/mg protein and/or carboxyatractyloside
(CATR) and bongkrekic acid (BA); Calcium (26.7–53.3 nmol/mg protein) was
then added to the preparation in order to induce the MPT pore. Mitochondrial
swelling traces are representative of six repetitions, each using different
mitochondrial preparations from separate animals. Legend: 0- Reference line; 1,
bongkrekic acid (BA); 2, Cyc A; 3, control (Ctrl); 4, CATR; 5, berberine
(berb); 6, BA þ berb; 7, CATR þ berb. (B) Data represent the amplitude of
absorbance measured before and 400 s after calcium addition. Bars represent
the mean ± SEM of six repetitions each analyzed by one-way ANOVA.
Differences were considered significant if p < 0.05. *, Ctrl versus BA, CATR,
and berb; þ, BA versus BA þ berb; #, BA þ berb versus Cyc A þ BA þ berb.
FIG. 4. Berberine does not cause mitochondrial swelling in nonenergized
mitochondria. Data represent the swelling amplitude before and 400 s after
calcium addition. Bars represent the mean ± SEM of three separate
experiments.
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observable in the presence of berberine (Fig. 6). Cyc A was
able to completely inhibit calcium-induced depolarization in
the presence of berberine and bongkrekic acid.
Berberine Decreases Mitochondrial Calcium Loading
Capacity
To obtain further evidence that berberine induces MPT pore
opening, mitochondrial calcium loading capacity in the
presence of different concentrations of the molecule was
evaluated. Increased MPT induction translates into a decrease
ability of mitochondria to retain calcium. Extramitochondrial
calcium levels were followed by using the fluorescent probe
Calcium Green 5N. After an increase in probe fluorescence due
to calcium addition, fluorescence decreased in all conditions
tested, indicating mitochondrial calcium uptake. However,
when berberine was present, calcium accumulation decreased
(Figs. 7A and 7B) when compared with the control.
As in previous results, the most critical piece of data
confirmed the berberine bypassed the inhibitory effect of
bongkrekic acid on calcium accumulation, whereas Cyc A was
able to prevent such effect. For the present study, only one
berberine concentration (133.3 nmol/mg protein) was used in
order to investigate the effect of ANT modulators.
Berberine does not Affect the Inhibitory Effect of ADP-
Oligomycin on ANT
Because bongkrekic acid did not inhibit the stimulatory
effect of berberine on the MPT, a possibility is that the ANT
would not be involved in the induction of the phenomenon by
berberine. To demonstrate the opposite, the next set of
experiments involved the use of ADP plus oligomycin, which
also acts on the ANT to inhibit pore opening. In fact, ADP is an
ANT ligand and a powerful MPT pore inhibitor (Crompton,
1999; Hagen et al., 2003). Oligomycin was added to avoid
mitochondrial ADP conversion into ATP.
In the presence of calcium, 33.3 and 66.7 nmol berberine/mg
protein decreases membrane potential in a concentration and
time-dependent manner, as it was described before. When
ADP-oligomycin was added to the mitochondrial suspension
no berberine-induced calcium-induced DW depolarization
FIG. 5. Berberine stimulates calcium-induced depolarization. Freshly
isolated mitochondria were energized with 5mM succinate/rotenone and
different concentrations of berberine (berb) were added to the solution.
Calcium (40–53.3 nmol of calcium/mg protein) was added to initiate time-
dependent transmembrane potential alterations, measured by a TPPþ electrode.
(A) Mitochondrial traces are representative of 7 repetitions, each using
mitochondrial preparations from separate animals. The values corresponde to
the Dw before (max) and 5 or 10 min after calcium addition. A, 6.6 nmol berb/
mg protein; B, 16.7 nmol berb/mg protein; C, 33.3 nmol berb/mg protein; D,
66.7 nmol berb/mg protein. (B) Bars represent the mean ± SEM of seven
repetitions each analyzed by one-way ANOVA. #, max versus 5, 10 min
(0, 6.7, 13.3, 33.3, and 66.7 nmol berb/mg protein); *, control (Ctrl) (5 min)
versus 5 min (6.7, 13.3, 33.3, and 66.7 nmol berb/mg protein); þ, Ctrl (10 min)
versus 10 min (6.7, 13.3, 33.3, and 66.7 nmol berb/mg protein).
FIG. 6. Berberine decreases mitochondrial calcium accumulation in-
dependent of bongkrekic acid presence. Freshly isolated mitochondria were
energized with 5mM succinate/rotenone and two different concentrations (33.3
and 66.7 nmol berberine/mg protein) were added to the solution in the presence
and absence of ANT inhibitors. Berberine induced a decrease in DW time and
concentration-dependent. Bars represent the mean ± SEM of six separate
experiments. d, carboxyatractyloside (CATR) (0.00) versus CATR (33.33)/
CATR (66.67); *, calcium (Ca) versus Berberine (berb) (33.3/66.7); þ,
Bongkrekic acid (BA) versus BA (33.3)/BA (66.7); #, BA (66.7) versus Cyc
A þ BA (66.7), numbers represent berberine concentration.
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occurred (Figs. 8A and 8B). In fact, DW was maintained for
several minutes after calcium addition.
Berberine Affects the Depolarizing Effect of Oleic Acid on
Mitochondria
Oleic acid–induced uncoupling of mitochondria is known to
be mediated by some anion carriers, including the ANT, as also
by uncoupling proteins (UCPs) (Khailova et al., 2006).
We observe from Figure 9A that to each oleic acid addition,
a small decrease in DW occurs. We quantified the average DW
decay in the first four additions of oleic acid.
The data (Fig. 9B) indicate that the two of the berberine
concentrations used increase the magnitude of oleic acid effects
on DW. Surprisingly, carboxyatractyloside was not able to
inhibit the depolarizing effect of oleic acid.
In order to verify if the effect of berberine on oleic acid–
induced depolarization was due to the depressive effect on DW
(Fig. 9, and see also Pereira et al., 2007), we used a small
amount of FCCP to clamp DW to a value similar to the one
obtained after incubation with 133.3 nmol berberine/mg protein.
No alteration on the effect of oleic acid was observed when the
DW was decreased with FCCP.
The Initial Depolarization Effect of Berberine is not
Dependent on the ANT
One particular effect observed when berberine is added to
energized mitochondria is a sudden mitochondrial depolariza-
tion followed by a partial recovery of DW to a value similar to
what is observed when berberine is preincubated with
mitochondria (Fig. 10A). By using the same concentrations
of bongkrekic acid and carboxyatractyloside used before we
confirmed that the immediate effects of berberine on
mitochondrial DW were not related with the ANT. In
opposition and as expected, ADP phosphorylation was
completely inhibited by both carboxyatractyloside and bongk-
rekic acid.
DISCUSSION
Phytomedicine, which involves the use of natural products
from traditional herbal medicines for medical and health-
fortifying purposes, is gaining international popularity. How-
ever, little is known about the mechanisms of action of their
active principles (Tsai and Tsai, 2004) although formulations
are widely in over the counter medications.
Previously, it was demonstrated that berberine increases
oxidative stress on isolated liver mitochondria and melanoma
cells. Increased oxidative stress is attributed to the interaction
of berberine at a site downstream of the rotenone binding site
(Pereira et al., 2007).
The inhibition of oxygen consumption by berberine is more
pronounced when respiratory substrates for complex I are used,
as described before (Barreto et al., 2003; Pereira et al., 2007).
Despite this, succinate-sustained respiration is also inhibited,
suggesting a larger range of targets in the respiratory chain
(Pereira et al., 2007). The effects on the ADP/O ratio, ADP
depolarization and lag phase (Pereira et al., 2007) suggests that
berberine interacts with the mitochondrial phosphorylative
system, although no effects on the mitochondrial ATPase were
found.
Because it was also observed that berberine induces the
calcium-induced MPT (Pereira et al., 2007), it is proposed that
berberine may also act on the ANT, a proposed component of
the pore complex.
The aim of the present investigation was then to identify
a common target responsible for both disruption of mitochon-
drial bioenergetics and the induction of the MPT. Our work
hypothesis is that the ANT is a target for berberine. Several
end-points for MPT induction were used, including calcium-
induced mitochondrial swelling, calcium-induced calcium
release and calcium-induced mitochondrial depolarization.
The three end-points are considered classic and sensitive
techniques to follow MPT induction induced by xenobiotics
(Bernardi and Forte, 2007).
FIG. 7. Assessment of mitochondrial calcium loading capacity in presence of different concentrations of berberine and ANT inhibitors. The fluorescent probe
Calcium Green 5-N (1lM) was used to evaluate the levels of extramitochondrial calcium as described under ‘‘Materials and Methods.’’ (A) Mitochondrial traces
are representative of six to seven repetitions, each using mitochondrial preparations from separate animals. (A) 0—control (Ctrl); 1—66.7 nmol berberine (berb)/
mg of protein; 2—133.3 nmol berb/mg of protein; 266.6 nmol berb/mg of protein. (B) 0—Cyc A/berb/bongkrekic acid (BA); 1—BA; 2—Ctrl;
3—carboxyatractyloside (CATR); 4—BA þ berb; 5—berb; 6—CATR þ berb. (B) Values indicate the difference in fluorescence values before and 300 s
after calcium (10–13.3 nmol/mg protein) addition. Bars represent the mean ± SEM of six to seven repetitions. *, calcium (Ca) (0) versus Ca (133.3 berb);d, CATR
(0) versus CATR (133.3 berb); n, BA (0) versus BA (133.3 berb); #, BA (133.3 berb) versus Cyc A þ BA (133.3 berb).
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The results of this investigation demonstrate that berberine
interacts with ANT on rat liver mitochondria, disturbing the
effect of bongkrekic acid as a MPT pore inhibitor. Calcium-
dependent mitochondrial swelling (Fig. 3) induced by the test
compound is in fact not inhibited by the ANT ligand
bongkrekic acid. Also, in some of the experimental protocols
used, berberine and carboxyatractyloside appear acting to-
gether to induce the MPT.
The results suggest a competition by berberine and
bongkrekic acid for a common binding place, or a conforma-
tional change on the ANT or surrounding lipid membrane
caused by berberine that decreases the affinity for bongkrekic
acid.
Interestingly, berberine was not able to induce the
permeability transition in nonenergized mitochondria which
suggests that a polarized inner membrane is required for the
effect of berberine, which is in accordance with previously
published data indicating that berberine accumulation in
mitochondria requires a transmembrane electrical potential.
Although berberine effects on the MPT were not inhibited
by bongkrekic acid, ADP plus oligomycin completely
prevented calcium-induced depolarization in the presence of
berberine. Because ADP is a potent pore inhibitor due to its
binding to the ANT (Crompton, 1999; Hagen et al., 2003), the
result confirm that berberine stimulates the MPT through an
interaction with the ANT and not to an unrelated mechanism.
Recently, it was reported that oleic acid stimulates
mitochondrial uncoupling mediated by anionic transporters,
such as the ANT, which causes a membrane potential decrease
and an increase in the respiratory rate of mitochondria
(Khailova et al., 2006). According to the fatty acid cycle
hypothesis, UCP and the ANT participate in an uncoupling
FIG. 8. ADP/oligomycin inhibits berberine stimulation of the MPT. A
TPPþ electrode was used to follow DW variations that occur during the MPT.
(A) Mitochondrial traces are representative of five different experiments. (A)
A—control (Ctrl); B—33.3 nmol berberine (berb)/mg protein; C—66.7 nmol
berb/mg protein; D—ADP þ oligomycin (oligo); E—ADP þ oligo þ 33.3
nmol berb/mg protein; F—ADP þ oligo þ 66.7 nmol berb/mg protein. (B) The
data describe the value of DW before and 5 min after calcium addition to
isolated mitochondria. Bars represent the mean ± SEM of five repetitions each
analyzed by one-way ANOVA. (*) Statistically different compared with the
control (p < 0.05). Legend: A—Ctrl; B—33.3 nmol berberine (berb)/mg
protein; C—66.7 nmol berb/mg protein; D—ADP þ oligo; E—ADP þ oligo þ
33.3 nmol berb/mg protein; F—ADP þ oligo þ 66.7 nmol berb/mg protein.
FIG. 9. Titration with oleic acid in the presence and absence of different
concentrations of berberine. (A) Mitochondrial traces are representative of nine
repetitions, each using mitochondrial preparations from separate animals. Each
oleic acid addition was equivalent to 0.84 nmol oleic acid/mg protein. (B)
Berberine increased oleic acid–induced mitochondrial depolarization. The data
indicate the average depolarization of four additions of oleic acid ¼ 6.88 nmol
oleic acid/mg protein total. Bars represent the mean ± SEM of nine repetitions.
(*) Statistically difference compared with control.
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process by facilitating the efflux of fatty acid anions through
hydrophobic barrier of the inner mitochondrial membrane
(Skulachev, 1991). According to this, a titration with oleic acid
was performed, in order to understand if berberine could also
affect with the depolarizing effect of oleic acid, by means of an
interaction with the ANT.
The results showed that berberine increases the effect of
oleic acid. Depolarization caused by oleic acid in mitochondria
was enhanced when different concentrations of berberine were
added to the suspension. The effects of berberine on oleic acid–
induced DW depolarization were not due to the decrease in DW
caused by berberine alone, as a small amount of FCCP did not
have the same effect. Interestingly and not as expected,
carboxyatractyloside did not inhibit the action of berberine.
The lack of inhibition is surprising after the results by Khailova
et al. (2006) and O’Brien et al. (2008). Nevertheless, it is also
likely that oleic acid effects are also different according to the
conformational state of ANT. According to our data,
apparently berberine facilitates the shuttling of oleic acid
across the mitochondrial membrane.
Finally, the role of the ANT in the sudden depolarization
observed upon berberine addition to a mitochondrial suspen-
sion was investigated. It must be stressed that the depolariza-
tion is transient and DW partly recovers, although to a value
lower than the control (Pereira et al., 2007).
The results show that berberine-induced depolarization was
not related with the ANT, once carboxyatractyloside and
bongkrekic acid had no effect (Fig. 10). The observation
indicates that for the concentrations at which both ANT
inhibitors hinder ADP phosphorylation, berberine-induced
depolarization was not avoided. This depolarization is not
Cyc A sensitive (data not shown) hence it is unlikely to be
MPT related. The DW depolarization is clearly different from
the one occurring when berberine and calcium are coincubated
with isolated mitochondrial fraction. In this case, it is the MPT
pore opening that triggers the loss of DW.
Interaction of berberine with the ANT may help explaining
the decreased ATP/ADP ratio found in melanoma cells (Pereira
et al., 2007) and the range of effects on isolated mitochondrial
fractions, although it must be stressed out that other ANT-
independent targets may exist, as uncoupled respiration was
also inhibited by berberine (Pereira et al., 2007).
The antitumor effect of berberine (Letasiova et al., 2006a, b;
Pereira et al., 2007) appears to possess a mitochondrial
component. Inhibition of the ANT in tumor cells can be an
advantage if the process results in cell death through induction
of the MPT and if a proper targeting and accumulation of the
molecule occurs. In fact, the positive moiety in the molecule
may be important for accumulating higher doses of berberine in
tumor cells. Accumulation of positively charged molecules into
mitochondria is driven by the negatively charged mitochondrial
matrix. Interestingly, it was previously demonstrated that
tumor development and progression is directly linked to the
magnitude of mitochondrial Dw in cancer cells (Heerdt et al.,
2005, 2006). It is reasonable to think that differences in
mitochondrial membrane potential between subpopulations of
tumor cells or even between normal and tumor cells (Dairkee
and Hackett, 1991; Davis et al., 1985; Nadakavukaren et al.,
1985; Ross et al., 2006) can be used to drive accumulation of
positively charged antitumor molecules. As discussed earlier,
berberine has other pharmacological indications although it is
not clear at the moment if mitochondrial effects can account for
its antimicrobial, antiarrhythmic or other pharmacological
properties. Nevertheless, it has been described that inhibition
of Complex I by berberine could account for its improvement
of whole-body insulin sensitivity (Turner et al., 2008).
The data from the present work appear to show that
berberine also presents some degree of toxicity to ‘‘nontumor’’
systems, which should be carefully understood. ANT inhibition
in nontumor cells by berberine would be responsible for
FIG. 10. Immediate depolarization of mitochondria by berberine is not
inhibited by ANT inhibitors. (A) Mitochondrial traces are representative of
eight repetitions, each using mitochondrial preparations from separate animals.
(A) A—control (Ctrl); B—carboxyatractyloside (CATR); C—bongkrekic acid
(BA) þ ADP; D—Ctrl; E—CATR; F—BA (þ 16.7 nmol berb/mg protein. (B)
Berberine induced a fast and immediate mitochondrial depolarization even in
the presence of CATR and BA. In a control situation (no berberine present)
CATR and BA prevented ADP depolarization of mitochondria, by inhibiting
the ANT. Bars represent the mean ± SEM of eight repetitions each analyzed by
one-way ANOVA. Differences were considered significant if the p value was
lower than 0.05. *, CATR þ berb versus ADP/CATR; þ, BA þ berb versus
ADP/BA; #, ADP versus ADP/CATR and ADP/BA.
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a decrease in energy production and could also result in MPT
induction. To the best of our knowledge, no full toxicity
assessment exists for berberine in humans, although its use in
several commercially available supplements suggests that the
compound may present a relatively wide safety interval. In fact,
a study with patients with congestive heart failure treated with
1.2 g/day of oral berberine revealed low toxicity and resulted
into an average plasma concentration of 0.11 mg/l which would
translate into 0.3lM (Zeng and Zeng, 1999). Repeated
cumulative treatments, alternative forms of formulation (e.g.,
topical application vs. injection) or more importantly, active
mitochondrial accumulation due to its positive charge would be
expected to increase its concentration in cells into the range of
concentrations used in this study.
Empirical data from nontraditional medicines plus the use of
extensive clinical assays would allow the use of berberine as
a promising antimelanoma agent while maintaining its safety
for humans. In radial/vertical forms of melanoma, a possible
topical application of berberine would also be possible, thus
minimizing side effects on other organs.
In conclusion, the present work identifies the ANT as an
important target for berberine, with clear relevance for its
proposed antitumor effects.
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